Literature DB >> 362207

Effects of inhaled beclomethasone dipropionate and alternate-day prednisone on pituitary-adrenal function in children with chronic asthma.

R Wyatt, J Waschek, M Weinberger, B Sherman.   

Abstract

Two corticosteroid regimens, alternate-day prednisone and inhaled beclomethasone dipropionate, have been more acceptable than daily oral corticosteroids for treatment of chronic asthma. To compare the effect of these regimens on hypothalamic-pituitary-adrenal function, 20 children with asthma were evaluated while receiving 20 to 40 mg of prednisone on alternate mornings or 400 to 800 microgram per day of inhaled beclomethasone dipropionate in divided daily doses; seven children requiring only non-corticosteroid medication served as controls. Early-morning serum cortisol concentration, urinary free-cortisol excretion and the 11-desoxycortisol response to metyrapone were decreased to a similar degree among children receiving both corticosteroid regimens in comparison with the control patients and were lowest when alternate-day prednisone and inhaled beclomethasone dipropionate were given together. Thus, inhaled beclomethasone dipropionate appears similar to alternate-day prednisone in its effect on hypothalamic-pituitary-adrenal function when used alone; the effect is additive when the two are used together.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 362207     DOI: 10.1056/NEJM197812212992504

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  20 in total

Review 1.  Pharmacotherapy of childhood asthma. An inflammatory disease.

Authors:  H P Van Bever; W J Stevens
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

2.  Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica.

Authors:  D M Reid; J J Nicoll; M A Smith; B Higgins; P Tothill; G Nuki
Journal:  Br Med J (Clin Res Ed)       Date:  1986-12-06

3.  Growth and childhood asthma.

Authors:  L Balfour-Lynn
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

4.  Perioperative respiratory assessment and management.

Authors:  P D Slinger
Journal:  Can J Anaesth       Date:  1992-05       Impact factor: 5.063

5.  Control of asthma.

Authors:  J Dolovich; F E Hargreave; W M Wilson; J Greenbaum; A C Powles; M T Newhouse
Journal:  Can Med Assoc J       Date:  1982-03-15       Impact factor: 8.262

6.  Effects of high doses of inhaled corticosteroids on adrenal function in children with severe persistent asthma.

Authors:  T K Ninan; I W Reid; P E Carter; P J Smail; G Russell
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

Review 7.  Inhaled corticosteroid therapy in children: an assessment of the potential for side effects.

Authors:  G Russell
Journal:  Thorax       Date:  1994-12       Impact factor: 9.139

8.  Naloxone and weight reduction: an exercise in introspection.

Authors:  T B Schwartz
Journal:  Trans Am Clin Climatol Assoc       Date:  1981

Review 9.  Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

10.  Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma.

Authors:  P Gustafsson; J Tsanakas; M Gold; R Primhak; M Radford; E Gillies
Journal:  Arch Dis Child       Date:  1993-08       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.